期刊
CHEMICAL COMMUNICATIONS
卷 57, 期 71, 页码 8993-8996出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d1cc02755g
关键词
-
资金
- National Natural Science Foundation of China (NSFC) [82061148009, 21872083]
The self-assembled carrier-free nanodrugs, IR820/ATO NPs, offer a superior photothermal therapy approach for breast cancer treatment by regulating mitochondrial metabolism, reducing ATP levels, and suppressing HSPs expression to enhance PTT sensitivity.
The oxidative phosphorylation inhibitor atovaquone (ATO) and the photosensitizer new indocyanine green (IR820) were self-assembled into carrier-free nanodrugs (IR820/ATO NPs) to achieve superior photothermal therapy (PTT), offering an attractive mitochondrial metabolism-regulatable approach for breast cancer treatment, where adenosine triphosphate (ATP) was downregulated along with downregulating the expression of heat shock proteins (HSPs) to amplify the sensitivity of PTT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据